Skip to content

Surgical Ablation of AF Efficacy Trial

Atrial Fibrillation | Heart Failure

SAFE is an international multicentre RCT of concomitant surgical atrial fibrillation (AF) ablation in patients with paroxysmal or persistent AF undergoing cardiac surgery.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* Age ≥ 18 years;
* Undergoing a clinically indicated cardiac surgical procedure: CABG, AVR, ascending aorta replacement, or combinations thereof;
* Documented history of paroxysmal or persistent AF
* Provide informed consent

Exclusion Criteria:

* Dominant atrial arrhythmia is atrial flutter;
* Documented left atrial diameter ≥ 6 cm;
* Previous cardiac surgery requiring opening of the pericardium;
* Patients undergoing any of the following procedures:

1. Heart transplant
2. Complex congenital heart surgery
3. Sole indication for surgery is ventricular assist device insertion
4. Mitral valve repair or replacement
5. Tricuspid valve repair or replacement
* Patient resides in a long-term care facility

Study Location

Hamilton General Hospital
Hamilton General Hospital
Hamilton, Ontario
Canada

Contact Study Team

Primary Contact

Richard Whitlock, MD PhD FRCSC

[email protected]
905-527-4322
Study Sponsored By
Population Health Research Institute
Participants Required
More Information
Study ID: NCT05434819